CVKD Next Earnings Date Notes

— Cadrenal Therapeutics (ticker: CVKD) is a clinical-stage biopharmaceutical company focused on developing tecarfarin, an investigational, novel oral anticoagulant targeted at cardiovascular indications such as atrial fibrillation (&AF) and for patients with an elevated risk of stroke who require chronic anticoagulation—particularly those with complications on warfarin or with kidney impairment. For investors tracking CVKD's progress ahead of each earnings call, key business metrics to monitor include tecarfarin's clinical trial milestones & regulatory updates, the size & timing of its addressable market, R&D expenses, liquidity/cash runway, and strategic partnerships or licensing activity. Long-term performance will be determined by the advancement of tecarfarin through pivotal trials and ultimately FDA approval prospects, as well as the company's ability to secure funding without dilutive equity raises. Also keep an ear out for management's commentary on patent position, collaborations, and their strategy for commercialization or partnering. Development timelines, safety/efficacy data, and shifts in the anticoagulation therapy landscape are crucial factors that can influence Cadrenal's valuation & growth trajectory. The next projected earnings date for CVKD is 3/27/2026 after close (stay tuned for a confirmed earnings date once announced).

CVKD Next Earnings Date FAQ

On this page we presented the CVKD Next Earnings Date information for Cadrenal Therapeutics along with recent past earnings dates. For Q3 of 2025, CVKD reported earnings of -1.310/share, with the earnings report taking place on 11/10/2025. For Q2 of 2025, CVKD reported earnings of -1.870/share, with the earnings report taking place on 8/11/2025. For Q1 of 2025, CVKD reported earnings of -2.090/share, with the earnings report taking place on 5/8/2025. For Q4 of 2024, CVKD reported earnings of -2.800/share, with the earnings report taking place on 3/13/2025. For Q3 of 2024, CVKD reported earnings of -2.180/share, with the earnings report taking place on 11/7/2024. Based on these past earnings dates, the projected next earnings date for CVKD is 3/27/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Cadrenal Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Cadrenal Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Cadrenal Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next CVKD earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up CVKD's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the CVKD next earnings date.